Glenza (Enzalutamide 40mg)

Glenza (Enzalutamide) is a generic androgen receptor inhibitor for castration-resistant prostate cancer from Glenmark, which is a listed and famous generic pharmaceutical manufacturer in India.

Enzalutamide cost:

Enzalutamide price for Glenza(Enzalutamide 40mg) in India is only 12% compare to the previous.

Enzalutamide dosage:

Enzalutamide 160 mg (four 40 mg capsules) administered orally once daily. Swallow capsules whole. Enzalutamide can be taken with or without food.

Patients receiving Enzalutamide should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy.

Enzalutamide Side Effects：

1. Seizure. If you take ENZALUTAMIDE you may be at risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure.

2.Posterior Reversible Encephalopathy Syndrome (PRES). If you take ENZALUTAMIDE you may be at risk of developing a condition involving the brain called PRES. Tell your healthcare provider right away if you have a seizure or quickly worsening symptoms such as headache, decreased alertness, confusion, reduced eyesight, blurred vision or other visual problems. Your healthcare provider will do a test to check for PRES.

3.Allergic Reactions. Allergic reactions have happened in people who take ENZALUTAMIDE. Stop taking ENZALUTAMIDE and get medical help right away if you develop swelling of the face, tongue, lip or throat.

4.Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with ENZALUTAMIDE. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with ENZALUTAMIDE. Call your healthcare provider or go to the nearest emergency room right away if you get chest pain or discomfort at rest or with activity or shortness of breath during your treatment with ENZALUTAMIDE.

5.Falls and fractures. ENZALUTAMIDE treatment may increase your risk for falls and fractures. Falls were not caused by loss of consciousness (fainting) or seizures. Your healthcare provider will monitor your risks for falls and fractures during treatment with ENZALUTAMIDE.

Enzalutamide Pi

For more Prescribing information，please check the → “FDA Prescribing Information”.